Bayer Healthcare Selects Liquent’s Insight Manager for Registrations to Improve Process Quality
Liquent, Inc. today announced that Bayer Healthcare (BHC), an independent subgroup of Bayer AG, Leverkusen, has selected Liquent InSight(R) Manager for Registrations (IMR). InSight Manager for Registrations is part of the Liquent InSight product family – an integrated, browser-based solution set that manages documents, submissions and product registration details from the time they are created, to their use in regulatory submissions, through to the end of the product lifecycle. IMR’s central repository enables global organizations to have the same view of product status, application status, and manufacturing details of pharmaceutical products and to ensure compliance.
With the help of IMR’s centralized view and management of product details, marketing authorizations and registrations, Bayer can ensure they are shipping compliant products. InSight Manager for Registrations will allow Bayer to continue improving their communication between headquarters, worldwide affiliates and partners as they manage their global registrations and product harmonization. With IMR, BHC will be able to automate the data exchange with internal, external and regulatory authority systems, such as the Eudra Vigilance Medical Product Dictionary (EVMPD).
“We chose Liquent because they understand our business environment and demonstrated excellent commitment during our extensive selection process. The services and functionality provided with IMR will support our requirements,” said Gerhard Schlueter, Head of Global Regulatory Operations at BHC Pharma.” With Liquent’s IMR state of the art browser-based architecture, flexible data model and intuitive user interface, Bayer will incorporate this solution into their existing enterprise-wide processes, knowing that they have the ability to perform enhancements at a much quicker pace and with a much lower cost of maintenance.
“Liquent’s regulatory solutions – including InSight, CoreDossier, and EZsubs – support an expanding group of more than 400 clients worldwide which include many of the largest German pharmaceutical organizations and six recent new clients in Europe,” said Jay Nadler, CEO of Liquent. “Life sciences organizations like Bayer Healthcare partner with Liquent because we are recognized as the market leader, we have a global presence to support their operations, we have the most regulatory expertise in the industry, and we have created InSight – the most complete regulatory product management solution designed to meet the needs of the changing regulatory environment. We look forward to working more closely with Bayer as they introduce IMR to their organization.”
About Bayer HealthCare AG
Bayer HealthCare AG, a subgroup of Bayer AG with sales of approximately 8.9 billion Euro in 2003, is one of the world’s leading, innovative companies in the health care and medical products industry.
The company combines the global activities of the divisions Animal Health, Biological Products, Consumer Care, Diagnostics and Diagnostics Self Testing Systems and Pharmaceuticals. 34,600 people are employed by Bayer HealthCare worldwide.
Our aim is to discover and manufacture innovative products that will improve human and animal health worldwide. Our products enhance well-being and quality of life by diagnosing, preventing and treating disease.
About Liquent, Inc.
Liquent, Inc. is the global leader in providing regulatory software solutions, information products, and related services for the life sciences industry. Liquent’s software and service offerings help ensure clients meet the strict standards of regulatory authorities across the world, helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time. In addition to technology and services, Liquent’s IDRAC database service provides the most comprehensive intelligence on the drug and biologics regulatory environment in 38 of the largest markets in the world.
As a result, 48 of the top 50 global life sciences companies rely on Liquent to stay current with the latest intelligence and to provide the technology and services to compress the regulatory submissions and approval process, improving speed to market, cost control, and productivity, all of which contribute to ensuring patients’ and physicians’ timely access to new drugs. Over the last decade, more than 5,000 regulatory submissions have been produced using Liquent’s world-class products and expert services.
Liquent’s headquarters are located in Horsham, Pennsylvania and its European headquarters reside in Chippenham, UK. Liquent has additional offices in Paris, France; Brunnthal, Germany; and Tokyo, Japan.
Liquent is a wholly owned subsidiary of Information Holdings Inc. (NYSE:IHI).
About Information Holdings, Inc.
Information Holdings Inc. is a leading provider of information products and services to intellectual property and life science markets. IHI’s data businesses, which include MicroPatent(R), Master Data Center(TM) and IDRAC, provide a broad array of databases, information products and complementary services for intellectual property and regulatory professionals. IHI’s Liquent unit is a leading provider of life science regulatory intelligence and publishing solutions.
